References
- Laurell C-B, Rannevik G. A comparison of plasma protein changes induced by danazol, pregnancy and estrogens. J Clin Endocrinol Metab 1979; 49: 719–25
- Damber MG, Sandstrom B, von Schoultz B, Stigbrand T. A new sensitive method for quantifying and comparing the biological potency of various estrogens in man. Acta Obstet Gynecol Scad 1979; 58: 527–30
- Von Schoultz B, Carlström K, Collste L, Eriksson A, Henriksson P, Pousette Å, et al. Estrogen therapy and liver function. Metabolic effects of oral and parenteral administration. The Prostate 1989; 14: 389–95
- Rannevik G, Thorell JI. The influence of danazol on pituitary function and on the ovarian follicular hormone secretion in premenopausal women. Acta Obstet Gynecol ScandSuppl 1984; 123: 89–94
- Dickey RP, Taylor SN, Curole DN. Serum estra-diol and danazol. 1. Endometnosis response, side effects, administration interval, concurrent spirono-lactone and dexamethasone. Fertil Steril 1986; 42: 709–16
- Steingold KA, Lu JKH, Judd HL, Meldrum DR. Danazol inhibits steroidogenesis by the human ovary. Fertil Steril 1986; 45: 649–54
- Barbieri RL, Canick JA, Makris A, Todd RB, Davies IJ, Ryan KJ. Danazol inhibits steroidogenesis. Fed Sted 1977; 28: 809–13
- Potts GO. Pharmacology of danazol. J Int Med ResSuppl 1977; 3: 1–14
- Rabe T, Kiesel L, Kellermann J, Weiden-Hammer K, Runnebaum B, Potts GO. Inhibition of human placental progesterone synthesis and aromatase activity by synthetic steroidogenic inhibitorsin vitro. Fertil Steril 1983; 39: 829–35
- Creange JE, Anzalone AJ, Potts GO, Schane HP. WIN 32729. A new potent interceptive agent in rats and rhesus monkeys. Contraception 1981; 24: 289–99
- Christiansen RG, Neumann HC, Salvador UJ, Bell MR, Schane HP, Creange JE, et al. Steroidogenesis inhibitors. I. Adrenal inhibitory and interceptive activity of trilostane and related compounds. J Med Chem 1984; 27: 928–31
- Snyder BW, Beecham GD, Schane HP. Inhibition of ovulation in rats with epostane, an inhibitor of 3β-hydroxysteroid dehydrogenase. Proc Soc Exp Biol Med 1984; 176: 238–42
- Snyder BW, Schane HP. Inhibition of luteal phase progesterone levels in the rhesus monkey by epostane. Contraception 1985; 31: 479–86
- Sterling-Winthrop Research Institute A summary of laboratory data on WIN. Sterling-Winthrop Research Institute, Rensselaer, New York 1981; 327: 29
- Slotman BJ, Rao BR. Response to inhibition of androgen action of human ovarian cancer cellsin vitro. Cancer 1989; 45: 213–20
- Rannevik G, Doeberl A, Valentin L. Epostane in non-pregnant females: effects on progesterone, 17α-hydroxyprogesterone and estradiol-17β of two dose Ievels given for one month. Fertil Steril 1988; 50: 893–902
- Van Look P, Bygdeman M. Antiprogestational steroids: a new dimension in human fertility regulation. Oxford Rev Reprod Biol 1989; 11: 1–60
- Birgerson L, Odlind V, Johansson EDB. Effects of epostane on progesterone synthesis in early human pregnancy. Contraception 1986; 33: 401–10
- Birgerson L, Ölund A, Odlind V, Somell C. Termination of early pregnancy with epostane. Contraception 1987; 35: 111–20
- Mainwaring MIP. Steroid hormone receptors: a survey. Vitamines Hormones 1975; 33: 223–45
- Laurell CB. Electroimmunoassay. Scand J Clin Lab InvestSuppl 1972; 124: 21–37
- Fernlund P, Gershagen S, Larsson I, Rannevik G. Radioimmunoassay of human sex hormone binding globulin: improved radioiodination procedure. Scand J Clin Lab Invest 1985; 45: 461–69
- Gershagen S, Doeberl A, Rannevik G. Changes in the SHBG concentration during danazol treatment. Acta Obstet Gynecol ScandSuppl 1984; 123: 117–23
- Von Schoultz B, Carlström K. On the regulation of sex hormone-binding globulin—a challenge of an old dogma and outlines of a new hypothesis. J Steroid Biochem 1989; 32: 327–34
- Ramevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Bod Y, Svanberg L. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary howones, SHBG and bone mineral density. Matmitan 1995; 21: 103–13
- Gershagen S, Doeberl A, Jeppsoon S, Rannevik G. Decreasing serum levels of sex hormone-binding globulin around the menopause and temporary relation to changing levels of ovarian steroids, as demonstrated in a longitudinal study. Fertil Steril 1989; 51: 616–21